Src inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo

Fiona Simpkins, Pedro Hevia-Paez, Jun Sun, Wendy Ullmer, Candace A. Gilbert, Thiago Da Silva, Ali Pedram, Ellis R. Levin, Isildinha M. Reis, Brian Rabinovich, Diana Azzam, Xiang Xi Xu, Tan A. Ince, Ji Yeon Yang, Roel G.W. Verhaak, Yiling Lu, Gordon B. Mills, Joyce M. Slingerland

Research output: Contribution to journal › Article › peer-review